Should We Shorten or Lengthen Postpolypectomy Surveillance Intervals?

  1. Douglas K. Rex, MD; and
  2. Sidney J. Winawer, MD
  1. From Indiana University School of Medicine, Indianapolis, IN 46202, and Memorial Sloan-Kettering Cancer Center, New York, NY 10065.

    TO THE EDITOR:

    In their recent article, Laiyemo and colleagues (1) were critical of the discriminatory value of current postpolypectomy surveillance guidelines, including the joint guidelines of the U.S. Multi-Society Task Force on Colorectal Cancer and the American Cancer Society (USMSTF–ACS). In the past 15 years, usual postpolypectomy practice surveillance intervals have expanded, first from 1 to 3 years and then from 3 to 5 years, in the cohort considered to be at lowest risk. The rationale for interval expansion is that surveillance has risks, costs, and less value than baseline clearing examinations …

    « Previous | Next Article »Table of Contents